For research use only. Not for therapeutic Use.
Fezolinetant hydrochloride (CAS 929016-98-8) is a selective and non-hormonal antagonist of the neurokinin-3 receptor (NK3R) currently under investigation for the treatment of menopausal symptoms. As a non-hormonal option, Fezolinetant HCl targets the neurokinin pathway, specifically blocking the action of neurokinin B. This mechanism is believed to mitigate the frequency and severity of hot flashes associated with menopause.
Catalog Number | I048012 |
CAS Number | 929016-98-8 |
Synonyms | Pracinostat Dihydrochloride |
Molecular Formula | C20H31ClN4O2 |
Purity | 98% |
Target | NK3 |
Target Protein | RCLMPSZFYQJPQD-VHPXAQPISA-N |
Appearance | Solid |
IUPAC Name | (E)-3-[2-butyl-1-[2-(diethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide;hydrochloride |
InChI | InChI=1S/C20H30N4O2.ClH/c1-4-7-8-19-21-17-15-16(10-12-20(25)22-26)9-11-18(17)24(19)14-13-23(5-2)6-3;/h9-12,15,26H,4-8,13-14H2,1-3H3,(H,22,25);1H/b12-10+ |
InChIKey | RCLMPSZFYQJPQD-VHPXAQPISA-N |
SMILES | CCCCC1=NC2=C(N1CCN(CC)CC)C=CC(=C2)C=CC(=O)NO.Cl |